D. E. Shaw & Co. Inc. Has $276.82 Million Holdings in Keurig Dr Pepper Inc (NYSE:KDP)

Share on StockTwits

D. E. Shaw & Co. Inc. grew its holdings in Keurig Dr Pepper Inc (NYSE:KDP) by 177.6% during the second quarter, Holdings Channel.com reports. The firm owned 9,578,432 shares of the company’s stock after acquiring an additional 6,128,458 shares during the quarter. D. E. Shaw & Co. Inc.’s holdings in Keurig Dr Pepper were worth $276,816,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. MRA Associates USA LLC acquired a new stake in shares of Keurig Dr Pepper in the second quarter valued at approximately $25,000. Pearl River Capital LLC acquired a new stake in shares of Keurig Dr Pepper in the second quarter valued at approximately $31,000. Penserra Capital Management LLC acquired a new stake in shares of Keurig Dr Pepper in the first quarter valued at approximately $40,000. Steward Partners Investment Advisory LLC acquired a new stake in shares of Keurig Dr Pepper in the second quarter valued at approximately $42,000. Finally, Trustcore Financial Services LLC raised its holdings in shares of Keurig Dr Pepper by 270.9% in the second quarter. Trustcore Financial Services LLC now owns 1,836 shares of the company’s stock valued at $53,000 after purchasing an additional 1,341 shares during the last quarter. Institutional investors own 19.53% of the company’s stock.

KDP traded down $0.29 during trading on Friday, reaching $27.32. 2,785,831 shares of the stock were exchanged, compared to its average volume of 2,297,241. The stock has a market cap of $39.32 billion, a P/E ratio of 26.27, a price-to-earnings-growth ratio of 1.49 and a beta of 0.45. Keurig Dr Pepper Inc has a twelve month low of $22.19 and a twelve month high of $31.06. The stock’s 50 day moving average price is $27.62 and its two-hundred day moving average price is $28.13. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.23 and a current ratio of 0.33.

Keurig Dr Pepper (NYSE:KDP) last issued its earnings results on Thursday, August 8th. The company reported $0.30 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.29 by $0.01. Keurig Dr Pepper had a net margin of 8.82% and a return on equity of 7.15%. The business had revenue of $2.81 billion for the quarter, compared to the consensus estimate of $2.86 billion. During the same period in the previous year, the company earned $1.30 earnings per share. The firm’s revenue for the quarter was up 196.3% on a year-over-year basis. Equities research analysts predict that Keurig Dr Pepper Inc will post 1.22 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 18th. Shareholders of record on Friday, October 4th will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Thursday, October 3rd. This represents a $0.60 dividend on an annualized basis and a yield of 2.20%. Keurig Dr Pepper’s dividend payout ratio (DPR) is 57.69%.

In related news, Director Robert S. Singer acquired 3,000 shares of Keurig Dr Pepper stock in a transaction on Tuesday, August 13th. The stock was purchased at an average cost of $28.65 per share, with a total value of $85,950.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Brian Andrew Loucks acquired 18,554 shares of Keurig Dr Pepper stock in a transaction on Wednesday, August 14th. The shares were bought at an average cost of $28.31 per share, with a total value of $525,263.74. The disclosure for this purchase can be found here. Over the last ninety days, insiders have acquired 62,727 shares of company stock valued at $1,447,441. Company insiders own 0.44% of the company’s stock.

A number of research firms have recently issued reports on KDP. Royal Bank of Canada set a $31.00 price objective on shares of Keurig Dr Pepper and gave the company a “buy” rating in a report on Friday, August 9th. Bank of America lifted their price objective on shares of Keurig Dr Pepper from $30.00 to $33.00 and gave the company a “buy” rating in a report on Friday, August 9th. Credit Suisse Group assumed coverage on shares of Keurig Dr Pepper in a report on Wednesday, July 17th. They issued a “neutral” rating and a $27.00 price objective on the stock. BMO Capital Markets upgraded shares of Keurig Dr Pepper from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $27.00 to $34.00 in a report on Monday, June 17th. Finally, ValuEngine downgraded shares of Keurig Dr Pepper from a “buy” rating to a “hold” rating in a report on Wednesday, September 4th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have assigned a buy rating to the stock. Keurig Dr Pepper has a consensus rating of “Buy” and an average target price of $30.27.

About Keurig Dr Pepper

Keurig Dr Pepper Inc operates as a beverage company in the United States and internationally. It operates through four segments: Beverage Concentrates, Packaged Beverages, Latin America Beverages, and Coffee Systems. The Beverage Concentrates segment manufactures and sells beverage concentrates. This segment also manufactures beverage concentrates into syrup.

See Also: QQQ ETF

Want to see what other hedge funds are holding KDP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Keurig Dr Pepper Inc (NYSE:KDP).

Institutional Ownership by Quarter for Keurig Dr Pepper (NYSE:KDP)

Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Federal Signal  Upgraded to Buy at Zacks Investment Research
Federal Signal Upgraded to Buy at Zacks Investment Research
GlaxoSmithKline’s  Neutral Rating Reaffirmed at JPMorgan Chase & Co.
GlaxoSmithKline’s Neutral Rating Reaffirmed at JPMorgan Chase & Co.
ChannelAdvisor  Raised to “Buy” at Zacks Investment Research
ChannelAdvisor Raised to “Buy” at Zacks Investment Research
Goldman Sachs Group Reiterates “Buy” Rating for Alliance Data Systems
Goldman Sachs Group Reiterates “Buy” Rating for Alliance Data Systems
VictoryShares US Discovery Enhanced Volatility Wtd ETF  Stock Price Up 1.1%
VictoryShares US Discovery Enhanced Volatility Wtd ETF Stock Price Up 1.1%
Packaging Corp Of America  Price Target Raised to $108.00 at Citigroup
Packaging Corp Of America Price Target Raised to $108.00 at Citigroup


© 2006-2019 Ticker Report